ATH-1017

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
ATH-1017 for Treatment of Mild to Moderate Alzheimer's DiseaseNCT04488419LeonaBioPhase 2, Phase 3Completed2024-07-15Actual
Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's DiseaseNCT04886063LeonaBioPhase 2, Phase 3Terminated2024-10-23Actual
A Study of ATH-1017 in Mild to Moderate Alzheimer's DiseaseNCT04491006LeonaBioPhase 2Completed2022-05-20Actual
ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)NCT04831281LeonaBioPhase 2Terminated2023-04-19Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.